Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells foradvanced malignant tumor.
Synergistic antitumor activity of immune strategies combined with radiation.
External beam radiation of tumor alters pheontype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Selective expansion of high-or low-avidity cytotoxic T lymphocytes efficacy for adoptive immunotherapy.
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy.
Effect of dose on immune response in patients vaccinated with an HER-2/neu intracellular domainprotein-based vaccine.
Age-related change in lymphocyte development and function.
Long-term Intravenous Administration of Activated Autologous Lymphocytes for Cancer Patients Does Not Induce Antinuclear Antibody and Rheumatoid Factor
Modulation of cell surface makers on NK-like T lycpmocytes by using IL-2, IL-7 or IL-12 in vitro stimulation
Activated T cells and cytokine-induced CD3+ CD56+ killer cells.
第 1 頁
第 2 頁
Coppyrightⓒ2019.All Rights Reserved
+Design By 藝創媒體